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ABSTRACT 
The purpose of this study was to formulate the crude aqueous leaf extract of Vernonia galamensis (used in folk medicine for the treatment of 
diabetes mellitus) into conventional tablets using three selected efflorescent diluents namely Aerosil® 200, Avicel® PH 101 and  calcium 
phosphate, due to the deliquescent nature of the extract. Attempted use of ordinary diluents for the tablet formulation had resulted to tablets 
defects. The crushing strength, friability, disintegration and dissolution times of tablets were determined using the methods specified in BP 
2007. The rank order of crushing strength - friability, disintegration time ratio (CSFR:DT) and dissolution rate values using gelatin as binder 
in terms of the three efflorescent diluents used was; calcium phosphate > Avicel
® PH 101  > Aerosil
® 200. Results indicate that good quality 
tablets of the deliquescent crude extract of Vernonia galamensis could be produced using the three selected efflorescent diluents with gelatin 
as binder but tablets produced using calcium phosphate as diluent were of best quality.  
Key words: Gelatin, crushing strength, disintegration, dissolution, tensile strength.     
   
INTRODUCTION 
Traditional herbalists have revealed the folkloric use of 
the  dried  powdered  leaves  of  Vernonia  galamensis 
(Asteraceae)  in  the  treatment  of  diabetes  mellitus.  But 
because  folkloric  medicines  have  no  standard  dose  or 
acceptable method of formulation
1, there is the need to 
standardize  and  formulate  them  in  conformity  with 
current  Good  Manufacturing  Practice  (GMP).  Some 
researchers  have  chosen  the  tablet  over  other  dosage 
forms for the formulation of medicinal plant extracts
2,3, 
due to the advantages of the former. Most plant extracts 
are  hygroscopic  and  susceptibility  to  microbial 
degradation, so the choice of a suitable pharmaceutical 
dosage  form  that  will  conform  to  GMP  cannot  be 
overemphasized. Tablets are by far the most frequently 
used  dosage  form  for  all  active  medicinal  ingredients; 
they  have  advantages  for  both  manufacturer  and  user. 
Ease  of  administration,  convenience  of  administration, 
and accurate dosing make tablets a versatile and popular 
dosage form
4. 
The  aim  of  this  study  was  to  formulate the  dry  crude 
leaves extract of Vernonia galamensis (EVG) into tablets 
in  accordance  with  current  GMP.  The  EVG  is  highly 
hydroscopic and deliquescent and is stored over silica gel 
in a desiccator. The use of common diluents like lactose, 
maize  starch  and  magnesium  carbonate  for  the 
formulation  produced  tablet  with  defects  especially 
‘sticking’ and ‘picking’ due to the deliquescent nature of 
the extract. But of paramount importance in this study 
was  the  use  of  gelatin  an  officially  approved 
pharmaceutical  binder,  and  carefully  selected 
efflorescent diluents for tablet formulation of the extract. 
The mechanical strengths of tablets were assessed using 
the crushing strength-friability, disintegration time ratio 
(CSFR:DT) and tensile strength. 
Tensile  strength  (TS)  is  a  method  of  measuring  the 
mechanical strength of tablets. It is the force required to 
break  a  tablet  in  a  diametral  compression  test.  It  is 
calculated from the equation: 
 TS = 2CS/πDd   
where  CS  is  the  crushing  strength  which  is  the  force 
required to break the tablet, D and d are the diameter and 
thickness  respectively
5.  Various  factors  e.g.  test 
conditions,  deformation  properties  of  the  material, 
adhesion conditions between compact and its support and 
tablet  shape  may  influence  the  measurement  of  the 
tensile strength.   
MATERIALS AND METHODS 
Leaves of Vernonia galamensis were collected from the 
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Zaria, Nigeria and was identified in the herbarium unit of 
the  Biological  Sciences  Department  the  University 
(voucher  specimen  number  994)  where  a  sample  has 
been  deposited.  The  leaves  were  washed,  air  dried, 
milled to a coarse (1000 µm) powder and macerated in 
distilled  water  for  24  h  at  room  temperature  and  the 
liquid  extract  filtered  through  a  calico  cloth  and 
concentrated to a ratio of 5:1 using a rotary evaporator. 
The concentrated filtrate was then transferred into a tray 
and dried  in an oven at 40  °C. The dried extract was 
pulverized using a mortar and pestle and passed through 
a 150 µm sieve and kept in an airtight desiccator. 
Preparation of Binder. –The required amount of gelatin 
(GLT)  powder  to  make  2.5,  5.0,  and  7.5%  w/v  was 
suspended  in  cold  water  and  allowed  to  hydrate.  The 
suspension  was  then  warmed  on  a  water  bath  until  a 
flowable  material  was  obtained.  To  avoid  gelling,  the 
suspension was kept warmed during use. 
Preparation of Granules. – The wet granulation method 
of  massing  and  screening  was  used.  Appropriate 
quantities of the dry extract and the diluent ratio 1:1.4 
were mixed in a mortar for 5 min. Disintegrant (maize 
starch, 6.8% w/w) was added and mixing continued for 
another  5  min.  The  liquid  binder  was  added  to  the 
powder mix in 2-mL portions and mixed with a pestle. 
The  moistened  mass  was  forced  through  a  1000  µm 
sieve, dried at 60 °C for 1 h to give a moisture content of 
4–6%,  determined  on  an  Ultra  X  moisture  balance 
(August  Gronert  Co.,  Germany).  The  granules  were 
again  passed  through  a  1000  µm  screen  to  break  up 
agglomerates. 
Particle Size Classification of Granules: - 50 g of the 
granules  was  placed  on  a  stack  of  seven  sieves  of 
descending mesh sizes of 1000 µm, 850 µm, 710 µm, 
600 µm, 500 µm, 250 µm and 150 µm. The sieves were 
vibrated  on  a  sieve  shaker  (Retsch  GmbH,  No. 
223110019, Type AS 200, Haan, Germany) for 15min. 
Thereafter  the  granules  retained  on  the  sieves  were 
divided into three groups as follows; >710 < 1000 µm, 
>500 < 710 µm and >150 < 500 µm, and weighed on a 
toploading balance. 
Preparation  of  Tablets.  –  The  tablet  formula  was 
designed  by  varying  the  types  and  quantities  of  the 
excipients with the ultimate view of obtaining tablets of 
highest quality (Table 1). Tablets equivalent to 300mg of 
granules were produced by compressing the granules for 
60  s  at  26.25  KN  (303  MNm
-2)  using  a  single  punch 
tablet  machine  (Tianxiang  and  Chentai  Pharmaceutical 
Machinery Co Ltd, Shanghai, China) fitted with 10.5mm 
flat punch and die set. Before each compression, the die 
(10.5 mm in diameter) and the flat-faced punches were 
lubricated  with  a  1%  (m/v)  dispersion  of  magnesium 
stearate in ethanol. After ejection, the tablets were stored 
over silica gel in a desiccator for 24 h to allow for elastic 
recovery and hardening
3.   
Analysis of Tablet – This was done as follows:  
Tablet  Diameter  and  Thickness;  the  tablet  diameter 
(D) and thickness (d) were determined to the nearest 0.01 
mm with a  Mitutoyo  model IDC-1012 EB  micrometer 
gauge (Mitutoyo Corporation, Japan).  
Crushing  Strength;  the  tablet  diametral  crushing 
strength was determined using the Erweka GmbH model 
MT  306404  tablet  hardness  tester.  The  mean  of  six 
readings was taken. 
Friability; ten (10) tablets were subjected to abrasion in 
a Roche friabilator at 25 rpm for 4 min. The weight of 
the tablets before and after friabilation was taken. The 
percentage  weight  loss  was  calculated  from  which 
percentage friability was determined. The mean of three 
readings was determined and where capping or fracture 
of tablets occurred, friability was not determined. 
Disintegration;  the  disintegration  times  of  the  tablets 
were determined according to the BP 2007 specifications 
using the Erweka disintegration tester (Erweka ZT 71, 
Germany). Distilled water thermostatically maintained at 
37 
oC was used as the disintegration medium. Six tablets 
were placed in the tubes of the tester, of which the lower 
end is fitted with a gauze disc made of rustproof wire. 
The disintegration apparatus was calibrated to operate at 
thirty  cycles  per  min.  For  each  batch  of  tablets  the 
experiment was repeated to yield three sets of readings.  
Dissolution  Rate; this  was  carried  out  using  the  USP 
XXIII  basket  method  using  the  Erweka  GmbH  model 
dissolution  tester,  Type  DT  80100328,  Germany.  
Tablets were placed in the medium and the stirrer rotated 
at 50 rpm in 900 mL of distilled water, maintained at 37 
± 0.5 °C. At 10 min intervals, samples of the dissolution 
medium were withdrawn with a syringe filtered through 
a filter paper of 0.2 um pore size. Equivalent amount of 
sample  volume  withdrawn  was  replaced  with  the 
dissolution  medium.  Drug  content  determination  was 
done by  measuring absorbance at 216 nm wavelength. 
The  dissolution  was  carried  out  on  three  tablets  from 
each  formulation.  A  calibration  curve  of  concentration 
versus  absorbance  values  was  plotted  using  various 
concentrations of the crude extract (0.2 to 1% w/v). The 
absorbance values were determined using the UV/Visible 
spectrophotometer ((Jenway 6405, Dunmow, Essex. UK. 
S/No.  2028))  at  a  fixed  wavelength  of  216  nm.  The 
dissolution times of tablets from the various formulations 
were  determined  by  extrapolation  of  the  absorbance 
readings from the calibration curve. 
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Stability Test 
Vernonia galamensis tablets were stored at a temperature 
of 30 ± 2 
oC and relative humidity of 75 ± 5 % for a 
period  of  twelve  (12)  months.  The  mechanical  and 
release properties of the tablets were assessed as earlier 
described. 
Data Analysis 
The  graphs  were  plotted  and  data  analyzed  using 
GraphPad Prism
® version 5.03 software. The data used 
to plot the graphs were the mean of three readings ± SD. 
RESULTS 
Table  2  presents  the  values  of  mean  granule  size, 
moisture content, crushing strength (CS), friability (FR), 
disintegration time (DT) and crushing strength-friability, 
disintegration  time  ratio  (CSFR:DT)  of  V.  galamensis 
tablets  produced  using  selected  diluents  Aerosil®  200 
(AR),  Avicel®  PH  (AV)  101  and    calcium  phosphate 
(CP) in combination with selected concentrations of GLT 
(2.5 %, 5.0 % and 7.5 % w/v) as binder. On a general 
note, the rank orders of CSFR:DT values for the three 
diluents, using GLT as binder at 2.5 %, 5.0 % and 7.5 % 
were similar and as follows; AV > CP > AR. This was 
further  simplified  in  figure  1  where  the  rank  order  of 
CSFR:DT was vividly seen to be; AV > CP > AR with 
the  highest  values  of  CSFR:DT  obtained  at  5  %  w/v 
concentration of the binder.  
 
Figure  2  depicts  the  tensile  strength  (TS)  -  pressure 
profile of EVG compacts formulated using CP as diluent 
and GLT as binder. All the granules exhibited significant 
sensitivity  to  changes  in  the  compaction  force.  TS 
increased up to 290 MNm
–2 for the whole granule size 
range,  thereafter,  further  increase  in  compaction  force 
results in a decrease in the compact TS.   
Drug release properties of tablets were characterized by 
the  disintegration  and  dissolution  times.  The  result  of 
spectrophotometric  analysis  shows  that  the  EVG 
exhibited  a  principal  absorption  maximum  at  216  nm 
typical for saponin alkaloids with a diene chromophore
6. 
Thus the calibration curve to assess the release properties 
of the tablets were determine at a wavelength of 216 nm 
and  the  linear  regression  equation  for  the  plot  of 
absorbance  versus  concentration  was  given  as  y  = 
0.1734x – 0.0043. The amount of drug (saponin alkaloid) 
released was plotted against time and the representative 
plots for tablets containing AV, CP and AR as diluents 
and GLT as binder were presented (Figure 1). The rank 
order  for  both  disintegration  time  (Table  2)  and 
dissolution time (Figure 3) were found to be the same as 
follows CP < AV < AR. 
 
 
DISCUSSION   
Previous studies have observed that increase in granule 
size leads to increase crushing strength of tablets and that 
this is as a result of increased surface irregularity of the 
larger  granules,  leading  to  an  increased  number  of 
binding surface areas
7. It was difficult to ascertain this 
fact in our study. On the contrary, we observed almost a 
complete reverse of that hypothesis. The effect of binder 
type  could  be  explained  as  the  reason  for  the 
discrepancies. For example gelatin and maize starch have 
been  found  to  have  higher  binding  effects  than 
polyvinylpyrrolidone
8. So if a  binder of  lower  binding 
capacity  is  used,  the  crushing  strength  will  be  low, 
regardless of granule size.  
Moisture  content  was  found  to  increase  as  the  binder 
concentration  was  increased,  with  a  corresponding 
increase  in  crushing  strength  (Table  2).  This  is  in 
agreement  with  previous  study  which  revealed  that 
increased binder concentration usually result in increase 
moisture content and increased tablet tensile strength
9. 
Crushing  strength-friability  ratio  (CSFR)  which  is  the 
quotient of the crushing strength (CS) value divided by 
the friability (FR) value, has been the index used as a 
measure  of  mechanical  strength  of  tablets
3.  But  the 
CSFR:DT which is a later index, is the quotient of the 
CSFR  value  divided  by  the  disintegration  time  (DT) 
value,  and  has  been  suggested  as  being  better  for 
measuring tablet quality. This is because in addition to 
measuring  tablet  strength  (crushing)  and  weakness 
(friability),  it  simultaneously  evaluates  all  negative 
effects of these parameters on disintegration time. Higher 
values of the CSFR:DT indicate a better balance between 
binding  and  disintegration  properties
10.  The  higher 
CSFR:DT and dissolution rate values obtained for tablets 
produced using CP and AV as diluents as presented in 
Table 2 and figure 3 respectively, could be explained by 
the presence of crystalline components in the CP and AV 
since crystals would normally disintegrate more easily in 
water  than  amorphous  materials.  CP  and  AV  contain 
crystalline  components  while  AR  is  completely 
amorphous
11.  Comparing  CP  and  AV  however,  tablet 
formulations  with  CP  have  higher  CSFR:DT  and 
dissolution rate values than those with AV (Figs. 4-6). 
This  could  be  as  a  result  of  a  decrease  surface 
irregularity,  leading  to  decrease  number  of  binding 
surface areas for binders in CP
2. 
It was also generally observed that for all three diluents 
used,  increase  in  binder  concentration  lead  to  increase 
crushing  strength,  decrease  friability  and  increase 
disintegration  time  of  tablets  (Table  2).  This  exactly 
follows the trend observed by Oyi et al
12, and it implies 
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IRJP 2 (6) June 2011       Page 138-143   
especially  in  chewable  tablets  and  lozenges,  higher 
binder concentrations can be used. 
The  TS  of  tablets  formulated  with  CP/PVP  increased 
with  increase  in  granule  particle  size.  This  means 
stronger bonds were formed within the particles as the 
particle size increased. The stronger bonds in the larger 
particles  could  be  a  result  of  an  increased  surface 
irregularity, leading to an increased number of binding 
surface  areas
2.  The  stronger  larger  particles  definitely 
required higher force to consolidate, dissipating energy 
and  resulting  in  increase  temperature.  As  the  tablet 
temperature  rises,  stress  relaxation  and  plasticity 
increases while elasticity decreases and strong compacts 
are formed
13,14. This agrees with previous works which 
revealed  that  compression  of  material  at  elevated 
temperature  with  increase  in  ductility  should  result  in 
stronger compacts
15.  
The tensile strengths for the EVG/CP tablets increased 
with increasing compaction force to their peaks levels at 
290 MNm–2 compaction force for the whole granule size 
range. Thereafter,  further  increase  in  compaction  force 
resulted in a decrease in the tablet tensile strengths. This 
can be ascribed to the possibility of the work associated 
with  compaction  above  290  MNm
–2  being  recovered 
during elastic relaxation, which results in a weakening of 
the  tablet  structure
16.  This  also  agrees  with  previous 
works  which  revealed  that  plastic  deformation  is 
believed to create the greatest number of clean surfaces 
and that because plastic deformation is a time dependent 
process, higher rate of force application should lead to 
the  formation  of  less  new  clean  surfaces  and  thus 
resulting in weaker tablets
17,18. 
CONCLUSION 
The dried EVG as prepared from the laboratory is highly 
hygroscopic and deliquescent and is permanently stored 
in a desiccator. Efforts in trying to use the usual common 
pharmaceutical  diluents  such  as  lactose,  maize  starch 
(MS) or magnesium carbonate for tablet formulation of 
the  deliquescent  plant  extract  proved  abortive  as  the 
resulting powder mixture or granules quickly absorbed 
moisture  and  become  sticky.  The  major  problems 
encountered with the tableting process were; (i) difficulty 
in  feeding  the  die,  the  granules  being  sticky,  and  (ii) 
‘tablet defects’ especially  ‘sticking’ and  ‘picking’. But 
understanding the definition of deliquescent materials as 
those materials that are highly hydrophilic and absorbed 
moisture  from  the  atmosphere  becoming  fluid,  it  was 
quite scientific and wise to look for efflorescent diluents. 
This  is  simply  due  to  the  knowledge  that  efflorescent 
materials are hydrophobic in nature and expel water, the 
aqueous tension of their hydrate being greater than the 
partial pressure of the water vapor in the air
19. A balance 
was  believed  to  be  achieved  along  the  line  where  the 
tendency of the deliquescent material to absorb moisture 
was  counteracted  by  the  ability  of  the  efflorescent 
material to expel all moisture.  
In  terms  of  mechanical  strength  therefore,  our  study 
revealed  that  good  quality  tablets  of  EVG  could  be 
produced  using  the  efflorescent  diluents;  AR,  AV  and 
CP,  regardless  of  binder  type.  When  we  included 
dissolution  test  results  however,  we  were  able  to 
conclude  that  using  GLT  as  binder,  the  best  quality 
tablets  of  EVG  could  be  produced  when  using  CP  as 
diluent compressed at 290 MNm-
2. 
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Table 1: Tablet formula for respective batches 
Material  Quantity per tablet (mg) 
Dried Aqueous Extract  115 
Diluents (aerosil
® 200, avicel
® PH 101, calcium phosphate)  155 
Endodisintegrant (Maize starch 6.8%w/w)  20.4 
Binder (Gelatin -  2.5, 5.0, and 7.5% w/w)  Qs 
Talc (3.0%w/w)  9.0 
Magnesium Stearate I (0.2%w/w)  0.6 
Theoretical tablet weight  300 ± 7.5 
 
 
 
Table 2: Values of granule size, moisture content and crushing strength-friability, disintegration time (CSFR/DT) ratio values for V.  galamensis granules and  tablets 
prepared using selected concentrations of gelatin (GLT) as binder. 
 
Diluent 
GLT 
(% w/v) 
Mean 
Granule size 
(um) 
Moisture 
Content (% 
w/w) 
 
CS (kgf) 
 
FR (%) 
 
DT (min) 
 
CSFR/DT 
AR  2.5  267±1.2  8.5±0.1  4.4±0.04  0.02±0.001  12.03±0.31  18.29 
AR  5.0  418±5.2  9,0±0.1  5.3±0.05  0.01±0.003  12.54±0.22  42.26 
AR  7.5  466±1.3  10.0±0.1  6.2±0.02  0.01±0.005  14.72±0.21  42.12 
AV  2.5  298±1.7  8.5±0.1  8.6±0.02  0.02±0.005  8.12±0.12  52.96 
AV  5.0  439±4.1  9.5±0.1  9.0±0.03  0.01±0.003  9.48±0.18  94.94 
AV  7.5  362±1.2  12.0±0.1  9.8±0.01  0.01±0.002  10.33±0.12  94.87 
CP  2.5  618±.2.1  9.5±0.1  3.9±0.01  0.02±0.003  5.57±0.22  70.02 
CP  5.0  435±7.2  11,0±0.1  4.2±0.04  0.01±0.001  5.65±0.18  74.34 
CP  7.5  557±2.3  13.0±0.1  4.8±0.02  0.01±0.003  6.46±0.16  74.30 
AR = aerosil
® 200, AV = avicel
® PH 101, CP = calcium phosphate 
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V ernonia galamensis le af  e xtract using se le cte d Dilue nts
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=
Fig. 2: Tensile Strength Vs Compression Pressure for tablets
prepared  using Cacium phosphate as Diluent and
Gelatin (GLT) 5% w/v as Binder
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=
Fig. 3: Percentage amount of drug release Vs Time of
Vernonia galamensis tablets produced using selected
diluents and gelatin (GLT) as Binder
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